Variant report
Variant | nsv970692 |
---|---|
Chromosome Location | chr6:92029835-92050275 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:92024328..92026291-chr6:92028411..92031026,2 | MCF-7 | breast: | |
2 | chr6:92039625..92040672-chr6:92243858..92245014,7 | MCF-7 | breast: | |
3 | chr6:92039721..92040294-chr6:93354118..93354772,2 | MCF-7 | breast: | |
4 | chr6:92039620..92040133-chr6:92244085..92244800,2 | MCF-7 | breast: | |
5 | chr6:92025048..92027862-chr6:92036199..92038247,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000265419 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs544398544 | chr6:92039765-92039766 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs540169533 | chr6:92039907-92039908 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs182929430 | chr6:92039941-92039942 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs187604977 | chr6:92039951-92039952 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs190217283 | chr6:92039998-92039999 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs560573069 | chr6:92039999-92040000 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs560063562 | chr6:92040012-92040013 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs144353407 | chr6:92040035-92040036 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs549403172 | chr6:92040038-92040039 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs562222818 | chr6:92040209-92040210 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs4361591 | chr6:92040304-92040305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs182848049 | chr6:92040357-92040358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs563016074 | chr6:92040404-92040405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs71540008 | chr6:92040426-92040427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs71932830 | chr6:92040427-92040428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs61367674 | chr6:92040460-92040461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs4053577 | chr6:92040461-92040462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs3223215 | chr6:92040465-92040466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs59265180 | chr6:92040467-92040468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs187194311 | chr6:92040489-92040490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs192569400 | chr6:92040520-92040521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs529538512 | chr6:92040531-92040532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs374113289 | chr6:92040558-92040559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs551671583 | chr6:92040617-92040618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs571477932 | chr6:92040650-92040651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs534128814 | chr6:92040818-92040819 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs552184507 | chr6:92040819-92040820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs547360169 | chr6:92040821-92040822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs568601679 | chr6:92040874-92040875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs146638668 | chr6:92040892-92040893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs566834238 | chr6:92040977-92040978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs4481406 | chr6:92040986-92040987 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs113237900 | chr6:92040999-92041000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs184412247 | chr6:92041015-92041016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188943982 | chr6:92041061-92041062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs79488225 | chr6:92041081-92041082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs193129757 | chr6:92041160-92041161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs184283515 | chr6:92041211-92041212 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs368886627 | chr6:92041227-92041228 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs35884704 | chr6:92041293-92041294 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs539039786 | chr6:92041301-92041302 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs2655651 | chr6:92041341-92041342 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs542638518 | chr6:92041479-92041480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs143218492 | chr6:92041481-92041482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs374114637 | chr6:92041495-92041496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs551611351 | chr6:92041505-92041506 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs151138092 | chr6:92041518-92041519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs568332694 | chr6:92041563-92041564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs534478802 | chr6:92041580-92041581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs2180126 | chr6:92041607-92041608 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 21364760 | CNVD |
Developmental delay | 19490664 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:92039800-92040000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
2 | chr6:92040000-92040600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
3 | chr6:92040600-92041000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr6:92040600-92041200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr6:92040800-92041200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr6:92040800-92041400 | Enhancers | Fetal Lung | lung |
7 | chr6:92040800-92041400 | Enhancers | Fetal Muscle Leg | muscle |
8 | chr6:92041200-92050600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
9 | chr6:92045400-92046400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr6:92048000-92050600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
11 | chr6:92049000-92049200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
12 | chr6:92049200-92049400 | ZNF genes & repeats | iPS-20b Cell Line | embryonic stem cell |
13 | chr6:92049400-92050600 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |